LSN-20576-52808 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-03
Dose 1 — Janssen/Johnson & Johnson
2022-01-31
Registered in v-safe
2022-01-31
Dose 2 — Moderna
2022-01-31
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2022-02-01
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2022-02-02
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Fatigue or tiredness, Nausea

Adult check-in
2022-02-03
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache

Adult check-in
2022-02-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Itching · None

Adult check-in
2022-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache

Adult check-in
2022-02-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · None

Adult check-in
2022-02-07
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2022-02-14
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2022-02-21
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2022-02-28
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2022-03-07
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2022-03-14
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-05-02
Survey response — 3 months, dose 2
MedDRA: Eye pruritus, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair

Free text: Runny nose, itchy eyes, covid negative

MedDRA releases: 2024-11 · check-in free text available
2022-08-01
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2023-01-31
Survey response — 12 months, dose 2
MedDRA: COVID-19, Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-03	Janssen/Johnson & Johnson	No
2	2022-01-31	Moderna	No

Free text

Release 11 — 3 months, dose 2

2022-05-02

Symptoms: Runny nose, itchy eyes, covid negative

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Eye pruritus	·	·	✓
SD	Influenza	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release